Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/41L stock hub

FRA/41L has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/41Lis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3.2B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/41L
In the news

Latest news · FRA/41L

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E21.4
P25 n/aP50 n/aP75 n/a
Trailing P/E24.4
P25 n/aP50 n/aP75 n/a
ROE20.5
P25 n/aP50 n/aP75 n/a
ROIC17.4
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/41L market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
216
Groups with data
11
Currency
EUR
Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Spain
Country code
DE
Employees
2,045
Employees Change
51%
Employees Change Percent
2.56
Enterprise value
EUR 3.2B
Exchange
Frankfurt Stock Exchange
Financial currency
EUR
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
EUR 3.2B
Price
EUR 62.8
Price currency
EUR
Rev Per Employee
370,913.41x
Sic
2834
Symbol
fra/41L
Website
https://www.rovi.es

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
4.1%
EV Earnings
24.61x
EV/EBIT
20.24x
EV/EBITDA
17.67x
EV/FCF
27.84x
EV/Sales
4.38x
FCF yield
3.63%
Forward P/E
21.43x
P/B ratio
4.68x
P/E ratio
24.39x
P/S ratio
4.34x
PE Ratio10 Y
30.61x
PE Ratio3 Y
22.56x
PE Ratio5 Y
21.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
21.61%
EBITDA Margin
24.75%
FCF margin
15.73%
Gross margin
63.97%
Gross Profit
EUR 474.1M
Gross Profit Growth
0.35%
Gross Profit Growth Q
2.75%
Gross Profit Growth3 Y
-2.64%
Gross Profit Growth5 Y
13.47%
Net Income
EUR 131.8M
Net Income Growth
-5.86%
Net Income Growth Q
-47.63%
Net Income Growth3 Y
-12.1%
Net Income Growth5 Y
13.18%
Pretax Margin
23.3%
Profit Margin
17.79%
Profit Per Employee
EUR 65,976
ROA
11.5
Roa5y
15.81
ROCE
20.57
ROE
20.48
Roe5y
31.03
ROIC
17.42
Roic5y
30.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

21
MetricValue
Cagr10y
16.82%
Cagr15y
19.76%
Cagr1y
24.73%
Cagr3y
16.9%
Cagr5y
7.47%
Div CAGR10
21%
Div CAGR3
-10.26%
Div CAGR5
10.95%
FCF Growth
39.98%
FCF Growth Q
-49.37%
FCF Growth3 Y
3.73%
FCF Growth5 Y
29.88%
OCF Growth
27.98%
OCF Growth Q
-31.23%
OCF Growth10 Y
16.31%
OCF Growth3 Y
4.67%
OCF Growth5 Y
20.37%
Revenue Growth
-3.44x
Revenue Growth Q
-1.55x
Revenue Growth3 Y
-3.07x
Revenue Growth5 Y
10.51x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 0.85
Assets
EUR 926.3M
Cash
EUR 97.4M
Current Assets
EUR 539.3M
Current Liabilities
EUR 147.5M
Debt
EUR 114.4M
Debt EBITDA
EUR 0.62
Debt Equity
EUR 0.17
Debt FCF
EUR 0.98
Equity
EUR 686.7M
Interest Coverage
58.95
Liabilities
EUR 239.6M
Long Term Assets
EUR 387M
Long Term Liabilities
EUR 92.1M
Net Cash
EUR -17M
Net Cash By Market Cap
EUR -0.53
Net Debt EBITDA
EUR 0.09
Net Debt Equity
EUR 0.02
Net Debt FCF
EUR 0.15
Tangible Book Value
EUR 638.8M
Tangible Book Value Per Share
EUR 12.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.66
Inventory Turnover
0.9
Net Working Capital
EUR 322.1M
Quick ratio
1.77
Working Capital
EUR 391.7M
Working Capital Turnover
EUR 2.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Dividend Growth
-15.28%
Dividend Growth Years
0%
Dividend per share
EUR 0.76
Dividend Years
16
Dividend Yield
1.11%
Ex Div Date
2025-07-14
Last Dividend
EUR 0.76
Payout Frequency
Annual
Payout Ratio
36.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
10Y total return
373.04%
1Y total return
24.71%
200-day SMA
66.68
3Y total return
59.79%
50-day SMA
80.09
50-day SMA vs 200-day SMA
50over200
5Y total return
43.38%
All Time High
91.3
All Time High Change
-31.22%
All Time High Date
2024-05-27
All Time Low
4.34
All Time Low Change
1,347%
All Time Low Date
2010-08-26
ATR
1.88
Ch YTD
-0.4
High
62.8
High52
85.65
High52 Date
2026-04-21
High52ch
-26.68%
Low
62.8
Low52
51.35
Low52 Date
2025-05-08
Low52ch
22.3%
Ma50ch
-21.58%
Price vs 200-day SMA
-5.82%
RSI
15.96
RSI Monthly
48.49
RSI Weekly
39.99
Sharpe ratio
0.64x
Sortino ratio
1.04
Total Return
1.11%
Tr YTD
-0.4
Tr15y
1,395.32%
Tr1m
-22.99%
Tr1w
-21.11%
Tr3m
-13.68%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 160.2M
Operating Income Growth
-12.22
Operating Income Growth Q
-56.75
Operating Income Growth3 Y
-13.35
Operating Income Growth5 Y
11.72
Operating margin
21.61

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

4
MetricValue
Float
16,296,127%
Net Borrowing
-308,000
Shares Institutions
15.34%
Shares Qo Q
0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
EUR 116.5M
Average Volume
4.3x
Bv Per Share
13.18
CAPEX
EUR -64.7M
Ch10y
328.2
Ch15y
1,143.6
Ch1m
-22.99
Ch1w
-21.11
Ch1y
23.02
Ch3m
-13.68
Ch3y
52.06
Ch5y
33.9
Ch6m
15.65
Change
-2.18%
Change From Open
0
Close
64.2
Days Gap
-2.18
Depreciation Amortization
23,278,000
Earnings Date
2026-05-06
EBIT
EUR 160.2M
EBITDA
EUR 183.4M
EPS
EUR 2.58
F Score
5
FCF
EUR 116.5M
FCF EV Yield
3.59x
Financing CF
-47,000,000
Fiscal Year End
December
Founded
1,946
Goodwill
2,702,000
Graham Number
27.87971
Graham Upside
-55.61
Income Tax
EUR 41M
Investing CF
-66,108,000
Is Primary Listing
0
Last Earnings Date
2026-05-06
Last Report Date
2026-03-31
Lynch Fair Value
EUR 33.94
Lynch Upside
-45.95
Ma150
69.91
Ma150ch
-10.18%
Ma20
80.03
Ma20ch
-21.53%
Net CF
68,085,000
Next Earnings Date
2026-07-23
Open
62.8
P FCF Ratio
27.58
P OCF Ratio
17.74
Payment Date
2025-07-16
Ppne
329,257,000
Price Date
2026-05-08
Price EBITDA
EUR 17.52
Ptbv Ratio
5.03
Relative Volume
0.48x
Revenue
741,085,000x
Tax By Revenue
5.53x
Tax Rate
23.72%
Tr6m
15.65%
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

FRA/41L dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.1%
$0.76 annual per share
Payout ratio
+36.3%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+10.9%
0 consecutive years of growth
Total shareholder yield
+1.1%
Next ex-dividend date: 2025-07-14
Performance

FRA/41L stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+24.7%
S&P 500 1Y: n/a
3Y total return
+59.8%
S&P 500 3Y: n/a
5Y total return
+43.4%
S&P 500 5Y: n/a
10Y total return
+373.0%
S&P 500 10Y: n/a
Ownership

Who owns FRA/41L?

Insider, institutional, and short-interest positioning.

Institutional ownership
+15.3%
Share of float held by funds and institutions
Insider ownership
n/a
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

FRA/41L momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
16.0
Below 30: short-term oversold
Price vs 200-day MA
-5.8%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.64
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/41L

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/41L stock rating?

fra/41L is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/41L analysis?

The full report lives at /stocks/fra/41L/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/41L?

The latest report frames fra/41L around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/41L page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.